1247587
1253147
1231040
1231048
1231051
COVID-19 Resources
The IDM has curated a go-to range of reliable information to guide and assist staff and students during this time of crisis. We are continuously updating the various COVID-19 resources listed on our webpage below.
Under construction – Building underway at the IDM
To make space for the growing staff complement at the IDM new construction has commenced.
The IDM - a cross-faculty, multidisciplinary postgraduate health research institute
Based on the UCT Faculty of Health Sciences campus in a 7,100 sqm state-of-the-art facility, we operate in the fields of infectious diseases and molecular medicine.
Clinical Research
Clinical research relevant to the needs of Africa's people
The IDM influences health policy and practice by translating our scientific discoveries and applying them in various communities; community relationships and trust are critical.
IDM Capacity Building
Capacity building in the IDM
The largest research entity at UCT, the IDM is a national leader in research and health sciences human capital development.

University accredited research institute | Tackling diseases of importance in Africa | Developing people | Impacting health policy and practice

Home > Home

News

Saturday, 25 September 2021
Why population immunity is not a realistic goal in Africa’s bid to control COVID-19

In public health, an important goal of vaccination and immunisation is to reach population or herd immunity. This is why the term comes up often in relation to the COVID-19 pandemic. And it helps to be clear about what it means.

Publication Date:
Tue, 17 Aug 2021 - 09:45
HIV infection may be driving drug resistance in tuberculosis

Results published recently in The Lancet Microbe detail analysis of 10 years’ health data, showing a relationship between HIV infection and acquisition of rifampicin resistance by tuberculosis (TB). Rifampicin is an important first‑line anti‑TB medication.

Publication Date:
Tue, 17 Aug 2021 - 09:30
T cells face off against variants to boost COVID-19 immunity

With the fight against COVID-19 beset with concerns around the efficacy of vaccines in the face of a mutating virus, University of Cape Town virologists have shown that the body’s T cells maintain 85% of their capacity to detect variants, continuing to mount a substantial defence to prevent severe illness, hospitalisation and death.

Publication Date:
Thu, 12 Aug 2021 - 09:30
Alan Pifer Award: A hat-tip to geneticist Professor Ambroise Wonkam

Growing up in Yaoundé, Cameroon, Professor Ambroise Wonkam pursued an atypical career path: medical research. Having decided early on in his education journey that he would follow an academic career, he thought one of the best ways to do this was through training in basic science. For him this meant exploring cell biology, which would end up being his gateway into genetics. An award-winning and world-renowned geneticist recognised for his work in sickle cell disease (SCD), he recently completed a three-year term as the Deputy Dean for Research (DDR) at the University of Cape Town’s (UCT) Faculty of Health Sciences (FHS). Professor Wonkam is one of two recipients of the 2020 Alan Pifer Award.

Publication Date:
Tue, 03 Aug 2021 - 15:00

Pages

TOP